Cabotegravir - Wikipedia
Cabotegravir, sold under the brand name Vocabria among others, is a antiretroviral medication used for the treatment of HIV/AIDS. It is available in the form of tablets and as an intramuscular injection , as well as in an injectable combination with rilpivirine under the brand name Cabenuva.
Cabotegravir: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年11月13日 · Cabotegravir is an antiviral medicine for HIV-1 that is available as an extended-release injection for HIV-1 PrEP (brand name Apretude) or as an oral tablet (brand name Vocabria) for the treatment of HIV-1 when used in combination with rilpivirine (Edurant), or alone as a daily lead-in dose to check tolerance to an extended-release cabotegravir ...
FDA Approves First Injectable Treatment for HIV Pre-Exposure …
Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms...
Cabotegravir: MedlinePlus Drug Information
Cabotegravir is used along with rilpivirine (Edurant) as a short-term treatment of human immunodeficiency virus type 1 (HIV-1) infection in certain adults and adolescents 12 years of age or older weighing at least 77 pounds (35 kg).
Cabotegravir (intramuscular route) - Mayo Clinic
Cabotegravir injection is used for pre-exposure prophylaxis (PrEP) to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection. HIV is the virus that causes acquired immune deficiency syndrome (AIDS).
Cabotegravir Patient Drug Record | NIH - Clinicalinfo
2024年2月7日 · Cabotegravir tablets and cabotegravir extended-release injectable suspension (also known as long-acting injectable cabotegravir) can be used for pre-exposure prophylaxis (PrEP) to reduce the risk of getting HIV in people who are HIV negative. Do not use cabotegravir for PrEP unless a health care provider has confirmed that you do not have HIV.
Vocabria (cabotegravir) - Uses, Side Effects, and More - WebMD
2024年9月29日 · Vocabria (cabotegravir) is commonly used for the following conditions. Short-term treatment of HIV (in combination with another medicine) Short-term prevention of HIV through sexual contact ( pre...
APRETUDE is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in at-risk adults and adolescents weighing at least 35 kg for PrEP to reduce the risk of sexually acquired HIV-1...
Cabotegravir, Cabotegravir Sodium (Monograph) - Drugs.com
2024年4月10日 · Cabotegravir sodium oral tablets (Vocabria) are used in combination with rilpivirine for short-term treatment of HIV-1 infection in adults and adolescents ≥12 years of age who weigh ≥35 kg and who are virologically suppressed (HIV-1 RNA<50 copies/mL) on a stable antiretroviral regimen, have no history of treatment failure, and have no known ...
Cabotegravir: Uses, Interactions, Mechanism of Action
2016年10月20日 · Cabotegravir, or GSK1265744, is an HIV-1 integrase inhibitor that is prescribed with the non-nucleoside reverse transcriptase inhibitor, rilpivirine. 4,6,7 Early research into cabotegravir showed it had lower oral bioavailability than dolutegravir, 4 which resulted in the development of long acting monthly intramuscular injection formulation ...